Koss-Olinger Consulting’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05M | Buy |
|
|||||
|
2025
Q1 | $1.11M | Sell |
|
|||||
|
2024
Q4 | $1.34M | Buy |
|
|||||
|
2024
Q3 | $746K | Sell |
|
|||||
|
2024
Q2 | $860K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.88M | Buy |
|
|||||
|
2023
Q3 | $1.14M | Buy |
|
|||||
|
2023
Q2 | $1.21M | Hold |
|
|||||
|
2023
Q1 | $972K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $2.05M | Buy |
|
|||||
|
2021
Q1 | $1.37M | Buy |
|